The Genetic Basis of the Polycystic Ovary Syndrome: A Literature Review Including Discussion of PPAR-gamma.

Abstract:

:Polycystic ovary syndrome (PCOS) is the most common endocrine disorder of the women of reproductive age. Familial clustering of PCOS has been consistently reported suggesting that genetic factors play a role in the development of the syndrome although PCOS cases do not exhibit a clear pattern of Mendelian inheritance. It is now well established that PCOS represents a complex trait similar to type-2 diabetes and obesity, and that both inherited and environmental factors contribute to the PCOS pathogenesis. A large number of functional candidate genes have been tested for association or linkage with PCOS phenotypes with more negative than positive findings. Lack of universally accepted diagnostic criteria, difficulties in the assignment of male phenotype, obscurity in the mode of inheritance, and particularly small sample size of the study populations appear to be major limitations for the genetic studies of PCOS. In the near future, utilizing the genome-wide scan approach and the HapMap project will provide a stronger potential for the genetic analysis of the syndrome.

journal_name

PPAR Res

journal_title

PPAR research

authors

Unluturk U,Harmanci A,Kocaefe C,Yildiz BO

doi

10.1155/2007/49109

subject

Has Abstract

pub_date

2007-01-01 00:00:00

pages

49109

eissn

1687-4757

issn

1687-4765

journal_volume

2007

pub_type

杂志文章
  • Regulation of Cell Proliferation and Differentiation by PPARbeta/delta.

    abstract::Peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) is a ligand-activated transcription factor with essential functions in the regulation of lipid catabolism, glucose homeostasis, and inflammation, which makes it a potentially relevant drug target for the treatment of major human diseases. In additi...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2008/614852

    authors: Müller R,Rieck M,Müller-Brüsselbach S

    更新日期:2008-01-01 00:00:00

  • Therapeutic Potential of PPARγ Activation in Stroke.

    abstract::Stroke (focal cerebral ischemia) is a leading cause of death and disability among adult population. Many pathological events including inflammation and oxidative stress during the acute period contributes to the secondary neuronal death leading the neurological dysfunction after stroke. Transcriptional regulation of g...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2008/461981

    authors: Vemuganti R

    更新日期:2008-01-01 00:00:00

  • Commonalities in the Association between PPARG and Vitamin D Related with Obesity and Carcinogenesis.

    abstract::The PPAR nuclear receptor family has acquired great relevance in the last decade, which is formed by three different isoforms (PPARα, PPARβ/δ, and PPAR ϒ). Those nuclear receptors are members of the steroid receptor superfamily which take part in essential metabolic and life-sustaining actions. Specifically, PPARG has...

    journal_title:PPAR research

    pub_type: 杂志文章,评审

    doi:10.1155/2016/2308249

    authors: Bandera Merchan B,Tinahones FJ,Macías-González M

    更新日期:2016-01-01 00:00:00

  • Fimasartan Ameliorates Nonalcoholic Fatty Liver Disease through PPARδ Regulation in Hyperlipidemic and Hypertensive Conditions.

    abstract::To investigate the effects of fimasartan on nonalcoholic fatty liver disease in hyperlipidemic and hypertensive conditions, the levels of biomarkers related to fatty acid metabolism were determined in HepG2 and differentiated 3T3-L1 cells treated by high fatty acid and liver and visceral fat tissue samples of spontane...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2017/8048720

    authors: Lee YJ,Jang YN,Han YM,Kim HM,Jeong JM,Seo HS

    更新日期:2017-01-01 00:00:00

  • PPARs, Cardiovascular Metabolism, and Function: Near- or Far-from-Equilibrium Pathways.

    abstract::Peroxisome proliferator-activated receptors (PPAR alpha, beta/delta and gamma) play a key role in metabolic regulatory processes and gene regulation of cellular metabolism, particularly in the cardiovascular system. Moreover, PPARs have various extra metabolic roles, in circadian rhythms, inflammation and oxidative st...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2010/783273

    authors: Lecarpentier Y,Claes V,Hébert JL

    更新日期:2010-01-01 00:00:00

  • Inhibition of Protein Farnesylation Arrests Adipogenesis and Affects PPARgamma Expression and Activation in Differentiating Mesenchymal Stem Cells.

    abstract::Protein farnesylation is required for the activation of multiple proteins involved in cell differentiation and function. In white adipose tissue protein, farnesylation has shown to be essential for the successful differentiation of preadipocytes into adipocytes. We hypothesize that protein farnesylation is required fo...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2007/81654

    authors: Rivas D,Akter R,Duque G

    更新日期:2007-01-01 00:00:00

  • Nicotinic acid-mediated activation of both membrane and nuclear receptors towards therapeutic glucocorticoid mimetics for treating multiple sclerosis.

    abstract::Acute attacks of multiple sclerosis (MS) are most commonly treated with glucocorticoids, which can provide life-saving albeit only temporary symptomatic relief. The mechanism of action (MOA) is now known to involve induction of indoleamine 2,3-dioxygenase (IDO) and interleukin-10 (IL-10), where IL-10 requires subseque...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2009/853707

    authors: Penberthy WT

    更新日期:2009-01-01 00:00:00

  • Zebrafish as a Model to Study the Role of Peroxisome Proliferating-Activated Receptors in Adipogenesis and Obesity.

    abstract::The Peroxisome Proliferator-Activated Receptors (PPARs) PPARA and PPARD are regulators of lipid metabolism with important roles in energy release through lipid breakdown, while PPARG plays a key role in lipid storage and adipogenesis. The aim of this review is to describe the role of PPARs in lipid metabolism, adipoge...

    journal_title:PPAR research

    pub_type: 杂志文章,评审

    doi:10.1155/2015/358029

    authors: Den Broeder MJ,Kopylova VA,Kamminga LM,Legler J

    更新日期:2015-01-01 00:00:00

  • Peroxisome proliferator activated receptor ligands as regulators of airway inflammation and remodelling in chronic lung disease.

    abstract::Inflammation is a major component in the pathology of chronic lung diseases, including asthma. Anti-inflammatory treatment with corticosteroids is not effective in all patients. Thus, new therapeutic options are required to control diverse cellular functions that are currently not optimally targeted by these drugs in ...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2007/14983

    authors: Ward JE,Tan X

    更新日期:2007-01-01 00:00:00

  • Activation of PPARγ by Rosiglitazone does not negatively impact male sex steroid hormones in diabetic rats.

    abstract::Peroxisome proliferator-activated receptor gamma (PPARγ) activation decreased serum testosterone (T) in women with hyperthecosis and/or polycystic ovary syndrome and reduced the conversion of androgens to estradiol (E2) in female rats. This implies modulation of female sex steroid hormones by PPARγ. It is not clear if...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2009/101857

    authors: Mansour M,Coleman E,Dennis J,Akingbemi B,Schwartz D,Braden T,Judd R,Plaisance E,Stewart LK,Morrison E

    更新日期:2009-01-01 00:00:00

  • PPAR-gamma Signaling Crosstalk in Mesenchymal Stem Cells.

    abstract::Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) is a member of the nuclear receptor (NR) superfamily of ligand-activated transcriptional factors. Among other functions, PPAR-gamma acts as a key regulator of the adipogenesis. Since several cytokines (IL-1, TNF-alpha, TGF-beta) had been known to inhibit ad...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2010/341671

    authors: Takada I,Kouzmenko AP,Kato S

    更新日期:2010-01-01 00:00:00

  • The Role of PPARgamma Receptors and Leukotriene B(4) Receptors in Mediating the Effects of LY293111 in Pancreatic Cancer.

    abstract::Pancreatic cancer is a devastating disease in which current therapies are inadequate. Separate lines of research have identified the 5-lipoxygenase/leukotriene B(4) receptor pathway and the PPARgamma pathway as potential targets for prevention or treatment of this disease. LY293111 was originally designed as a potent ...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2008/827096

    authors: Adrian TE,Hennig R,Friess H,Ding X

    更新日期:2008-01-01 00:00:00

  • The PPAR Ω Pocket: Renewed Opportunities for Drug Development.

    abstract::The past decade of PPARγ research has dramatically improved our understanding of the structural and mechanistic bases for the diverging physiological effects of different classes of PPARγ ligands. The discoveries that lie at the heart of these developments have enabled the design of a new class of PPARγ ligands, capab...

    journal_title:PPAR research

    pub_type: 杂志文章,评审

    doi:10.1155/2020/9657380

    authors: Kaupang Å,Hansen TV

    更新日期:2020-07-01 00:00:00

  • HMGB1 Is Involved in the Protective Effect of the PPAR α Agonist Fenofibrate against Cardiac Hypertrophy.

    abstract::High mobility group box 1 (HMGB1) is a ubiquitous nuclear DNA-binding protein whose function is dependent on its cellular location. Extracellular HMGB1 is regarded as a delayed mediator of proinflammatory cytokines for initiating and amplifying inflammatory responses, whereas nuclear HMGB1 has been found to prevent ca...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2014/541394

    authors: Jia Z,Xue R,Liu G,Li L,Yang J,Pi G,Ma S,Kan Q

    更新日期:2014-01-01 00:00:00

  • Downregulation of the proinflammatory state of circulating mononuclear cells by short-term treatment with pioglitazone in patients with type 2 diabetes mellitus and coronary artery disease.

    abstract::Background. This study was performed to investigate the influence of a short-term treatment with pioglitazone versus placebo on inflammatory activation of mononuclear cells (mRNA expression/protein secretion of inflammatory markers). Methods and Results. Sixty-three patients with well-controlled type 2 diabetes (52 ma...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2011/647017

    authors: Pfützner A,Weise A,Pfützner-Riehn E,Lübben G,Morcos M,Karagiannis E,Weber M,Forst T

    更新日期:2011-01-01 00:00:00

  • The Role of PPARs in Placental Immunology: A Systematic Review of the Literature.

    abstract::Pregnancy is a state of immunotolerance, and pregnancy outcome is strongly linked to the correct activation and balancing of the maternal immune system. Besides abortion as possible result of improper early pregnancy development, other pregnancy associated conditions like preeclampsia (PE), intrauterine growth retarda...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2013/970276

    authors: Hutter S,Knabl J,Andergassen U,Jeschke U

    更新日期:2013-01-01 00:00:00

  • PPAR Action in Human Placental Development and Pregnancy and Its Complications.

    abstract::During pregnancy crucial anatomic, physiologic, and metabolic changes challenge the mother and the fetus. The placenta is a remarkable organ that allows the mother and the fetus to adapt to the new metabolic, immunologic, and angiogenic environment imposed by gestation. One of the physiologic systems that appears to h...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2008/527048

    authors: Wieser F,Waite L,Depoix C,Taylor RN

    更新日期:2008-01-01 00:00:00

  • Combined Rosiglitazone and Forskolin Have Neuroprotective Effects in SD Rats after Spinal Cord Injury.

    abstract::The peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist rosiglitazone inhibits NF-κB expression and endogenous neural stem cell differentiation into neurons and reduces the inflammatory cascade after spinal cord injury (SCI). The aim of this study was to explore the mechanisms underlying rosiglitazone-me...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2018/3897478

    authors: Meng QQ,Lei W,Chen H,Feng ZC,Hu LQ,Zhang XL,Li S

    更新日期:2018-06-21 00:00:00

  • Inhibition of Carrageenan-Induced Cutaneous Inflammation by PPAR Agonists Is Dependent on Hepatocyte-Specific Retinoid X ReceptorAlpha.

    abstract::It has been proposed that PPAR-dependent, accelerated catabolism of proinflammatory mediators may contribute to the fast resolution of inflammation. Because retinoid X receptors are obligate heterodimer partners of PPARs, we investigated the impact of deleting hepatocyte-specific RXRalpha on the antiedema effect of PP...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/PPAR/2006/96341

    authors: Wan YJ,Badr MZ

    更新日期:2006-01-01 00:00:00

  • PPARs Expression in Adult Mouse Neural Stem Cells: Modulation of PPARs during Astroglial Differentiaton of NSC.

    abstract::PPAR isotypes are involved in the regulation of cell proliferation, death, and differentiation, with different roles and mechanisms depending on the specific isotype and ligand and on the differentiated, undifferentiated, or transformed status of the cell. Differentiation stimuli are integrated by key transcription fa...

    journal_title:PPAR research

    pub_type: 杂志文章,收录出版

    doi:10.1155/2007/48242

    authors: Cimini A,Cristiano L,Benedetti E,D'Angelo B,Cerù MP

    更新日期:2007-01-01 00:00:00

  • PPARgamma: The Portrait of a Target Ally to Cancer Chemopreventive Agents.

    abstract::Peroxisome proliferator-activated receptor-gamma (PPARgamma), one of three ligand-activated transcription factors named PPAR, has been identified as a molecular target for cancer chemopreventive agents. PPARgamma was initially understood as a regulator of adipocyte differentiation and glucose homeostasis while later o...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2008/436489

    authors: Sainis I,Vareli K,Karavasilis V,Briasoulis E

    更新日期:2008-01-01 00:00:00

  • Inhibitors of Fatty Acid Synthesis Induce PPAR α -Regulated Fatty Acid β -Oxidative Genes: Synergistic Roles of L-FABP and Glucose.

    abstract::While TOFA (acetyl CoA carboxylase inhibitor) and C75 (fatty acid synthase inhibitor) prevent lipid accumulation by inhibiting fatty acid synthesis, the mechanism of action is not simply accounted for by inhibition of the enzymes alone. Liver fatty acid binding protein (L-FABP), a mediator of long chain fatty acid sig...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2013/865604

    authors: Huang H,McIntosh AL,Martin GG,Petrescu AD,Landrock KK,Landrock D,Kier AB,Schroeder F

    更新日期:2013-01-01 00:00:00

  • The Emerging Role of PPAR Beta/Delta in Tumor Angiogenesis.

    abstract::PPARs are ligand-activated transcriptional factors that belong to the nuclear receptor superfamily. Among them, PPAR alpha and PPAR gamma are prone to exert an antiangiogenic effect, whereas PPAR beta/delta has an opposite effect in physiological and pathological conditions. Angiogenesis has been known as a hallmark o...

    journal_title:PPAR research

    pub_type: 杂志文章,评审

    doi:10.1155/2020/3608315

    authors: Du S,Wagner N,Wagner KD

    更新日期:2020-08-13 00:00:00

  • Potential Therapeutic Use of PPARgamma-Programed Human Monocyte-Derived Dendritic Cells in Cancer Vaccination Therapy.

    abstract::Dendritic cells (DCs) can regulate all elements of the immune system, and therefore are an ideal target for vaccination. During the last two decades, as a result of extensive research, DCs became the primary target of antitumor vaccination as well. A critical issue of antitumor vaccination is the phenotype of the dend...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2008/473804

    authors: Gyöngyösi A,Nagy L

    更新日期:2008-01-01 00:00:00

  • Involvement of the Retinoid X Receptor Ligand in the Anti-Inflammatory Effect Induced by Peroxisome Proliferator-Activated Receptor γ Agonist In Vivo.

    abstract::Peroxisome proliferator-activated receptor γ (PPARγ) forms a heterodimeric DNA-binding complex with retinoid X receptors (RXRs). It has been reported that the effect of the PPAR agonist is reduced in hepatocyte RXR-deficient mice. Therefore, it is suggested that the endogenous RXR ligand is involved in the PPARγ agoni...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2011/840194

    authors: Yamamoto A,Kakuta H,Miyachi H,Sugimoto Y

    更新日期:2011-01-01 00:00:00

  • Pparg may Promote Chemosensitivity of Hypopharyngeal Squamous Cell Carcinoma.

    abstract::The upregulation of peroxisome proliferator-activated receptor gamma (PPARG) has been shown to increase the chemosensitivity of several human cancers. This study is aimed at studying if PPARG sensitizes hypopharyngeal squamous cell carcinoma (HSCC) in chemotherapeutic treatments and at dissecting possible mechanisms o...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2020/6452182

    authors: Lian M,Chen J,Shen X,Hou L,Fang J

    更新日期:2020-04-22 00:00:00

  • The Effect of PPAR Agonists on the Migration of Mature and Immature Eosinophils.

    abstract::PPARγ agonists can either enhance or inhibit eosinophil migration, which is a sum of directional migration (chemotaxis) and random cell movement (chemokinesis). To date, the effects of PPAR agonists on chemokinesis have not been examined. This study investigates the effects of PPARα, δ, and γ agonists on eosinophil mi...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2012/235231

    authors: Smith SG,Imaoka H,Punia N,Irshad A,Janssen LL,Sehmi R,Gauvreau GM

    更新日期:2012-01-01 00:00:00

  • Structural Development Studies of Subtype-Selective Ligands for Peroxisome Proliferator-Activated Receptors (PPARs) Based on the 3,4-Disubstituted Phenylpropanoic Acid Scaffold as a Versatile Template.

    abstract::Improvements in our understanding of the functions of the nuclear receptor peroxisome proliferator-activated receptor (PPAR) subtypes as pleiotropic regulators of biological responses, including lipid, lipoprotein, glucose homeostasis, inflammation, differentiation and proliferation of various cancer cells, and memory...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2008/689859

    authors: Miyachi H,Hashimoto Y

    更新日期:2008-01-01 00:00:00

  • The role of peroxisome proliferator-activated receptors in colorectal cancer.

    abstract::Colorectal cancer is one of the most common cancers in the world. Dietary fat intake is a major risk factor for colorectal cancer. Some nuclear hormone receptors play an important role in regulating nutrient metabolism and energy homeostasis. Among these receptors, special attention has been focused on the role of per...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2012/876418

    authors: Park JI,Kwak JY

    更新日期:2012-01-01 00:00:00

  • Caffeoylquinic Acid-Rich Extract of Aster glehni F. Schmidt Ameliorates Nonalcoholic Fatty Liver through the Regulation of PPARδ and Adiponectin in ApoE KO Mice.

    abstract::Aster glehni is well known for its therapeutic properties. This study was performed to investigate the effects of A. glehni on nonalcoholic fatty liver disease (NAFLD) in atherosclerotic condition, by determining the levels of biomarkers related to lipid metabolism and inflammation in serum, liver, and adipose tissue....

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2017/3912567

    authors: Lee YJ,Jang YN,Han YM,Kim HM,Jeong JM,Son MJ,Jin CB,Kim HJ,Seo HS

    更新日期:2017-01-01 00:00:00